Subjective well-being in early-phase schizophrenia patients using long-acting injectable versus oral antipsychotic drugs: Data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)

Abstract Background This analysis evaluated potential differences in subjective well-being (SW) among patients with early-phase schizophrenia (SZ) randomized to treatment with either long-acting injectable (LAI) or oral aripiprazole or paliperidone within the “European Long-acting Antipsychotics i...

Full description

Bibliographic Details

Published in:	European Psychiatry
Main Authors:	Anna-Theresa Schulze, Timo Schurr, Fabienne Post, Beatrice Frajo-Apor, Covadonga M. Díaz-Caneja, Walter Wolfgang Fleischhacker, Michael Davidson, Alex Hofer
Format:	Article
Language:	English
Published:	Cambridge University Press 2025-01-01
Subjects:	early-phase schizophrenia long-acting injectable antipsychotics personal recovery subjective well-being
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933825100862/type/journal_article